These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 33842335)

  • 1. Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis.
    Dong S; Wang Z; Shen K; Chen X
    Front Oncol; 2021; 11():629666. PubMed ID: 33842335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review.
    Cantiello F; Cicione A; Salonia A; Autorino R; De Nunzio C; Briganti A; Gandaglia G; Dell'Oglio P; Capogrosso P; Damiano R
    Int J Urol; 2015 Jan; 22(1):22-32. PubMed ID: 25345683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feeding the critically ill obese patient: a systematic review protocol.
    Secombe P; Harley S; Chapman M; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular mechanisms between metabolic syndrome and breast cancer.
    Chen Y; Wen YY; Li ZR; Luo DL; Zhang XH
    Biochem Biophys Res Commun; 2016 Mar; 471(4):391-5. PubMed ID: 26891869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
    Vona-Davis L; Howard-McNatt M; Rose DP
    Obes Rev; 2007 Sep; 8(5):395-408. PubMed ID: 17716297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study.
    Agnoli C; Berrino F; Abagnato CA; Muti P; Panico S; Crosignani P; Krogh V
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):41-8. PubMed ID: 19361966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and breast cancer: an overview.
    Gezgen G; Roach EC; Kizilarslanoglu MC; Petekkaya I; Altundag K
    J BUON; 2012; 17(2):223-9. PubMed ID: 22740197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FEATURES OF BREAST CANCER IN PATIENTS OF YOUNG AGE: SEARCH FOR DIAGNOSIS OPTIMIZATION AND PERSONALIZED TREATMENT.
    Chekhun V; Martynyuk О; Lukianova Y; Mushii O; Zadvornyi T; Lukianova N
    Exp Oncol; 2023 Oct; 45(2):139-150. PubMed ID: 37824778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple risk factors for cardiovascular disease and diabetes mellitus.
    Smith SC
    Am J Med; 2007 Mar; 120(3 Suppl 1):S3-S11. PubMed ID: 17320520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of the metabolic syndrome.
    Daskalopoulou SS; Mikhailidis DP; Elisaf M
    Angiology; 2004; 55(6):589-612. PubMed ID: 15547646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and chronic kidney disease.
    Ching-Ha Kwan B; Beddhu S
    Minerva Urol Nefrol; 2006 Mar; 58(1):1-12. PubMed ID: 16760879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure control and components of the metabolic syndrome: the GOOD survey.
    Zidek W; Naditch-Brûlé L; Perlini S; Farsang C; Kjeldsen SE
    Cardiovasc Diabetol; 2009 Sep; 8():51. PubMed ID: 19754934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Metabolic Syndrome in Endometrial Cancer: A Review.
    Yang X; Wang J
    Front Oncol; 2019; 9():744. PubMed ID: 31440472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic comorbidities and the association with risks of recurrent metastatic disease in breast cancer survivors.
    Anwar SL; Cahyono R; Prabowo D; Avanti WS; Choridah L; Dwianingsih EK; Harahap WA; Aryandono T
    BMC Cancer; 2021 May; 21(1):590. PubMed ID: 34022845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Syndrome in Type 2 Diabetes Mellitus Patients: Prevalence, Risk Factors, and Associated Microvascular Complications.
    Asghar S; Asghar S; Shahid S; Fatima M; Bukhari SMH; Nadeem Siddiqui S
    Cureus; 2023 May; 15(5):e39076. PubMed ID: 37323312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial to evaluate the effects of combined progressive exercise on metabolic syndrome in breast cancer survivors: rationale, design, and methods.
    Dieli-Conwright CM; Mortimer JE; Schroeder ET; Courneya K; Demark-Wahnefried W; Buchanan TA; Tripathy D; Bernstein L
    BMC Cancer; 2014 Apr; 14():238. PubMed ID: 24708832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Syndrome and the Risk of Thyroid Cancer: A Nationwide Population-Based Cohort Study.
    Park JH; Choi M; Kim JH; Kim J; Han K; Kim B; Kim DH; Park YG
    Thyroid; 2020 Oct; 30(10):1496-1504. PubMed ID: 32524894
    [No Abstract]   [Full Text] [Related]  

  • 19. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.